BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $563,000 | -22.1% | 7,662 | 0.0% | 0.76% | -11.3% |
| Q2 2019 | $723,000 | +4.3% | 7,662 | -11.5% | 0.86% | -11.0% |
| Q1 2019 | $693,000 | -30.6% | 8,662 | -53.2% | 0.96% | -28.7% |
| Q4 2018 | $999,000 | -55.9% | 18,528 | -36.2% | 1.35% | -36.4% |
| Q3 2018 | $2,267,000 | +23.0% | 29,036 | 0.0% | 2.12% | +25.7% |
| Q2 2018 | $1,843,000 | -29.8% | 29,036 | +1.4% | 1.69% | -38.6% |
| Q1 2018 | $2,627,000 | +21.6% | 28,646 | 0.0% | 2.75% | +24.7% |
| Q4 2017 | $2,160,000 | +25.4% | 28,646 | +15.8% | 2.21% | +4.6% |
| Q3 2017 | $1,723,000 | +46.1% | 24,735 | +6.3% | 2.11% | +18.2% |
| Q2 2017 | $1,179,000 | – | 23,273 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |